Title: Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.
Journal: Journal of medicinal chemistry20140911
Title: Newer antipsychotics and upcoming molecules for schizophrenia.
Journal: European journal of clinical pharmacology20130801
Title: Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice.
Journal: Expert opinion on pharmacotherapy20130301
Title: Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults.
Journal: Expert review of clinical pharmacology20130101
Title: Development and validation of automated SPE-HPLC-MS/MS methods for the quantification of asenapine, a new antipsychotic agent, and its two major metabolites in human urine.
Journal: Biomedical chromatography : BMC20121201
Title: New serotonin/dopamine antagonists for the treatment of schizophrenia: are we making real progress?
Journal: Clinical schizophrenia & related psychoses20121001
Title: Pharmacological and clinical profile of recently approved second-generation antipsychotics: implications for treatment of schizophrenia in older patients.
Journal: Drugs & aging20121001
Title: Iloperidone, asenapine and lurasidone: a primer on their current status.
Journal: Expert opinion on pharmacotherapy20120901
Title: Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
Journal: CNS drugs20120901
Title: Clinically important differences in the pharmacokinetics of the ten newer 'atypical' antipsychotics: Part 2. Metabolism and elimination.
Journal: Journal of psychiatric practice20120901
Title: A systematic review of meta-analyses of the efficacy of oral atypical antipsychotics for the treatment of adult patients with schizophrenia.
Journal: Expert opinion on pharmacotherapy20120801
Title: Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow.
Journal: Synapse (New York, N.Y.)20120701
Title: Long-term efficacy and safety of asenapine or olanzapine in patients with schizophrenia or schizoaffective disorder: an extension study.
Journal: Pharmacopsychiatry20120701
Title: Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians.
Journal: Postgraduate medicine20120701
Title: ▼Asenapine for bipolar I disorder?
Journal: Drug and therapeutics bulletin20120601
Title: [Asenapine in bipolar disorder: efficacy, safety and place in clinical practice].
Journal: L'Encephale20120601
Title: Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
Journal: Journal of managed care pharmacy : JMCP20120601
Title: Valproate reduces the glucuronidation of asenapine without affecting asenapine plasma concentrations.
Journal: Journal of clinical pharmacology20120501
Title: Short-term safety and pharmacokinetic profile of asenapine in older patients with psychosis.
Journal: International journal of geriatric psychiatry20120501
Title: Asenapine: a clinical review of a second-generation antipsychotic.
Journal: Clinical therapeutics20120501
Title: Clinically important differences in the pharmacokinetics of the ten newer 'atypical' antipsychotics: part 1.
Journal: Journal of psychiatric practice20120501
Title: Allergic reactions and sudden death with asenapine.
Journal: The Journal of clinical psychiatry20120501
Title: Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration.
Journal: Neuropharmacology20120301
Title: [Antipsychotic medications for bipolar I disorders. New atypical neuroleptic drug asenapine approved].
Journal: Der Nervenarzt20120301
Title: Interactions between antiepileptics and second-generation antipsychotics.
Journal: Expert opinion on drug metabolism & toxicology20120301
Title: Quantification of asenapine and three metabolites in human plasma using liquid chromatography-tandem mass spectrometry with automated solid-phase extraction: application to a phase I clinical trial with asenapine in healthy male subjects.
Journal: Biomedical chromatography : BMC20120201
Title: Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension.
Journal: Journal of clinical psychopharmacology20120201
Title: Asenapine versus olanzapine in people with persistent negative symptoms of schizophrenia.
Journal: Journal of clinical psychopharmacology20120201
Title: The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup.
Journal: The western journal of emergency medicine20120201
Title: Asenapine: a synthesis of efficacy data in bipolar mania and schizophrenia.
Journal: Clinical schizophrenia & related psychoses20120101
Title: The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease.
Journal: Parkinson's disease20120101
Title: Update on the role of antipsychotics in the treatment of Tourette syndrome.
Journal: Neuropsychiatric disease and treatment20120101
Title: Critical appraisal of lurasidone in the management of schizophrenia.
Journal: Neuropsychiatric disease and treatment20120101
Title: Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.
Journal: Clinical neuropharmacology20120101
Title: Safety and tolerability of switching to asenapine from other antipsychotic agents: pooled results from two randomized multicenter trials in stable patients with persistent negative symptoms in schizophrenia.
Journal: Neuropsychiatric disease and treatment20120101
Title: Stability-indicating liquid chromatographic method for the quantification of the new antipsychotic agent asenapine in bulk and in pharmaceutical formulation.
Journal: Scientia pharmaceutica20120101
Title: Smoking and metabolism; asenapine; irreversible MAOIs.
Journal: Psychosomatics20120101
Title: Asenapine: a review of acute and extension phase data in bipolar disorder.
Journal: CNS neuroscience & therapeutics20111201
Title: System for disclosing hospitality should be transparent.
Journal: BMJ (Clinical research ed.)20111115
Title: Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder.
Journal: Pharmacopsychiatry20111101
Title: Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis.
Journal: Lancet (London, England)20111008
Title: Attenuation of chronic mild stress-induced 'anhedonia' by asenapine is not associated with a 'hedonic' profile in intracranial self-stimulation.
Journal: Journal of psychopharmacology (Oxford, England)20111001
Title: Biological perspectives: update on newer antipsychotic drugs: are they evidence based?
Journal: Perspectives in psychiatric care20111001
Title: Asenapine: a new antipsychotic option.
Journal: Journal of pharmacy practice20111001
Title: Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.
Journal: JAMA20110928
Title: Functional potencies of dopamine agonists and antagonists at human dopamine D₂ and D₃ receptors.
Journal: European journal of pharmacology20110901
Title: Suicidal ideation associated with asenapine use: a report of 2 cases.
Journal: Journal of clinical psychopharmacology20110801
Title: Asenapine pharmacokinetics in hepatic and renal impairment.
Journal: Clinical pharmacokinetics20110701
Title: Unmet treatment needs in schizophrenia patients: is asenapine a potential therapeutic option?
Journal: Expert review of neurotherapeutics20110701
Title: Asenapine for the treatment of stuttering: an analysis of three cases.
Journal: The American journal of psychiatry20110601
Title: Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism.
Journal: Psychopharmacology20110401
Title: Metabolism and excretion of asenapine in healthy male subjects.
Journal: Drug metabolism and disposition: the biological fate of chemicals20110401
Title: Dual inhibition: a novel promising pharmacological approach for different disease conditions.
Journal: The Journal of pharmacy and pharmacology20110401
Title: Update on newer antipsychotic drugs.
Journal: Journal of psychosocial nursing and mental health services20110401
Title: Newer molecules in the treatment of schizophrenia: A clinical update.
Journal: Indian journal of pharmacology20110401
Title: Dopamine D2 occupancy as a biomarker for antipsychotics: quantifying the relationship with efficacy and extrapyramidal symptoms.
Journal: The AAPS journal20110301
Title: Asenapine: a review of its use in the management of mania in adults with bipolar I disorder.
Journal: CNS drugs20110301
Title: A randomized placebo-controlled trial of asenapine for the prevention of relapse of schizophrenia after long-term treatment.
Journal: The Journal of clinical psychiatry20110301
Title: Iloperidone, asenapine, and lurasidone: a brief overview of 3 new second-generation antipsychotics.
Journal: Postgraduate medicine20110301
Title: The role of serotonin receptors in the action of atypical antipsychotic drugs.
Journal: Current opinion in pharmacology20110201
Title: Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology20110101
Title: Comparison of QTc data analysis methods recommended by the ICH E14 guidance and exposure-response analysis: case study of a thorough QT study of asenapine.
Journal: Clinical pharmacology and therapeutics20110101
Title: Atypical antipsychotics: the two new arrivals.
Journal: Issues in mental health nursing20110101
Title: Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysis.
Journal: BMC psychiatry20110101
Title: Weight gain, obesity, and psychotropic prescribing.
Journal: Journal of obesity20110101
Title: Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?
Journal: Annals of general psychiatry20110101
Title: The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder.
Journal: Neuropsychiatric disease and treatment20110101
Title: Role of sublingual asenapine in treatment of schizophrenia.
Journal: Neuropsychiatric disease and treatment20110101
Title: Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials.
Journal: BMC psychiatry20110101
Title: Clinical potential of lurasidone in the management of schizophrenia.
Journal: Therapeutics and clinical risk management20110101
Title: Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder.
Journal: Patient preference and adherence20110101
Title: Clinical utility of the risperidone formulations in the management of schizophrenia.
Journal: Neuropsychiatric disease and treatment20110101
Title: Asenapine: a clinical overview.
Journal: The Journal of clinical psychiatry20110101
Title: Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat.
Journal: Behavioural brain research20101225
Title: A review of new atypical antipsychotic launches in the United States.
Journal: Psychiatry (Edgmont (Pa. : Township))20101201
Title: Asenapine for long-term treatment of bipolar disorder: a double-blind 40-week extension study.
Journal: Journal of affective disorders20101101
Title: Effects of asenapine on prefrontal N-methyl-D-aspartate receptor-mediated transmission: involvement of dopamine D1 receptors.
Journal: Synapse (New York, N.Y.)20101101
Title: Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder.
Journal: Pharmacotherapy20100901
Title: New antipsychotic drugs: how do their receptor-binding profiles compare?
Journal: The Journal of clinical psychiatry20100901
Title: Evaluation of the clinical efficacy of asenapine in schizophrenia.
Journal: Expert opinion on pharmacotherapy20100801
Title: Effect of absorption site on the pharmacokinetics of sublingual asenapine in healthy male subjects.
Journal: Biopharmaceutics & drug disposition20100701
Title: Long-term assessment of Asenapine vs. Olanzapine in patients with schizophrenia or schizoaffective disorder.
Journal: Pharmacopsychiatry20100601
Title: Pharmacology and efficacy of asenapine for manic and mixed states in adults with bipolar disorder.
Journal: Expert review of neurotherapeutics20100501
Title: Repeated effects of asenapine on adrenergic and cholinergic muscarinic receptors.
Journal: The international journal of neuropsychopharmacology20100401
Title: Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
Journal: Journal of affective disorders20100401
Title: Efficacy and safety of asenapine in a placebo- and haloperidol-controlled trial in patients with acute exacerbation of schizophrenia.
Journal: Journal of clinical psychopharmacology20100401
Title: Asenapine induces differential regional effects on serotonin receptor subtypes.
Journal: Journal of psychopharmacology (Oxford, England)20100301
Title: New drug information. Saphris.
Journal: JAAPA : official journal of the American Academy of Physician Assistants20100301
Title: Asenapine (Saphris) sublingual tablets for schizophrenia and bipolar disorder.
Journal: The Medical letter on drugs and therapeutics20100208
Title: New drugs: asenapine, iloperidone, and bepotastine besilate.
Journal: Journal of the American Pharmacists Association : JAPhA20100101
Title: A genetic network model of cellular responses to lithium treatment and cocaine abuse in bipolar disorder.
Journal: BMC systems biology20100101
Title: [The quest for the pharmacological treatment of schizophrenia: from conventional neuroleptics to atypical antipsychotics and beyond].
Journal: Vertex (Buenos Aires, Argentina)20100101
Title: Neuroleptic malignant syndrome after exposure to asenapine: a case report.
Journal: Primary care companion to the Journal of clinical psychiatry20100101
Title: Asenapine, a new sublingual atypical antipsychotic.
Journal: Journal of pharmacology & pharmacotherapeutics20100101
Title: Asenapine versus olanzapine in acute mania: a double-blind extension study.
Journal: Bipolar disorders20091201
Title: Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic.
Journal: International journal of clinical practice20091201
Title: Asenapine maleate: a new drug for the treatment of schizophrenia and bipolar mania.
Journal: Drugs of today (Barcelona, Spain : 1998)20091201
Title: Asenapine effects in animal models of psychosis and cognitive function.
Journal: Psychopharmacology20091101
Title: A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states.
Journal: Bipolar disorders20091101
Title: Exposure-response analysis in patients with schizophrenia to assess the effect of asenapine on QTc prolongation.
Journal: Journal of clinical pharmacology20091101
Title: Asenapine.
Journal: Nature reviews. Drug discovery20091101
Title: Asenapine approved for treatment of schizophrenia, bipolar disorder.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists20090915
Title: Asenapine.
Journal: CNS drugs20090901
Title: Modeling and simulation of the time course of asenapine exposure response and dropout patterns in acute schizophrenia.
Journal: Clinical pharmacology and therapeutics20090701
Title: Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms.
Journal: Psychopharmacology20090601
Title: Asenapine exerts distinctive regional effects on ionotropic glutamate receptor subtypes in rat brain.
Journal: Synapse (New York, N.Y.)20090501
Title: Electrophysiological characterization of the effects of asenapine at 5-HT(1A), 5-HT(2A), alpha(2)-adrenergic and D(2) receptors in the rat brain.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology20090301
Title: Asenapine: a novel psychopharmacologic agent with a unique human receptor signature.
Journal: Journal of psychopharmacology (Oxford, England)20090101
Title: Asenapine restores cognitive flexibility in rats with medial prefrontal cortex lesions.
Journal: Psychopharmacology20090101
Title: Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder.
Journal: Neuropsychiatric disease and treatment20090101
Title: Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology20081101
Title: Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to G alpha s.
Journal: European journal of pharmacology20080707
Title: Acute and long-term treatment of mania.
Journal: Dialogues in clinical neuroscience20080601
Title: Bipolar depression: trial-based insights to guide patient care.
Journal: Dialogues in clinical neuroscience20080601
Title: American psychiatric association.
Journal: P & T : a peer-reviewed journal for formulary management20080601
Title: Differential regional and dose-related effects of asenapine on dopamine receptor subtypes.
Journal: Psychopharmacology20080501
Title: Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia.
Journal: Psychopharmacology20080201
Title: Efficacy and tolerability of asenapine in acute schizophrenia: a placebo- and risperidone-controlled trial.
Journal: The Journal of clinical psychiatry20071001
Title: Drug-drug interactions associated with second-generation antipsychotics: considerations for clinicians and patients.
Journal: Psychopharmacology bulletin20070101
Title: Asenapine in the treatment of negative symptoms of schizophrenia: clinical trial design and rationale.
Journal: Psychopharmacology bulletin20070101
Title: Actions of ORG 5222 as a novel psychotropic agent.
Journal: Pharmacology, biochemistry, and behavior19900301
Title: M Shahid, et al. Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. J Psychopharmacol. 2009 Jan;23(1):65-73.
Title: Olivia Frånberg, et al. Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia. Psychopharmacology (Berl). 2008 Feb;196(3):417-29.
